Global Clinical Nutrition Market Overview 2023-2028
The global clinical nutrition market size reached US$ 47.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 78.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2023-2028.
Clinical nutrition refers to the branch of nutrition that focuses on the application of nutrition science and principles to promote optimal health and manage medical conditions in clinical settings. It involves assessing, diagnosing, and treating nutritional problems and developing personalized nutrition plans to support overall health and address specific medical conditions. It considers the unique nutritional needs of patients based on their age, sex, medical history, and specific requirements related to their condition. It is used in the prevention and management of various diseases and the recovery and rehabilitation of individuals with medical conditions.
Global Clinical Nutrition Market Trends and Drivers:
The surging prevalence of chronic conditions, such as diabetes, cardiovascular diseases, and cancer, which often require special dietary needs, and the rising aging population who are more prone to develop such diseases, represent one of the primary factors driving the demand for clinical nutrition around the world. Moreover, the increasing cases of food allergies and intolerances, such as gluten and lactose intolerance, are bolstering the market growth. In addition, the growing inclination towards personalized medicine is influencing the market positively. Apart from this, the rising number of preterm births and the inflating need for clinical nutrition in the pediatric medicine segment is favoring the growth of the market.
Global Clinical Nutrition Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc and Reckitt Benckiser Group PLC
The report segmented the market on the basis of region, product, route of administration, application and end user.
Breakup by Product:
- Infant Nutrition
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
- Oral
- Enteral
- Parenteral
Breakup by Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Breakup by End User:
- Pediatric
- Adults
- Geriatric
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
